HR Execs on the Move

Oerth Bio

www.oerthbio.com

 
At Oerth Bio™, we are on a mission to change perceptions of agricultural chemistry We are leading a new and transformative approach to crop protection, crop health and healthy food by leveraging our proprietary PROTAC® protein degraders, or proteolysis-targeting chimeras. PROTAC protein degraders work by harnessing the plant`s own natural protein disposal system to degrade and remove unwanted proteins. We are an early-stage agriculture biotechnology company located in the heart of downtown Durham, North Carolina.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oerthbio.com
  • 112 South Duke Street Suite 1
    Durham, NC USA 27701
  • Phone: 435.901.2146

Executives

Name Title Contact Details
John Dombrosky
Chief Executive Officer Profile

Similar Companies

Falcon Consulting Group

Falcon Consulting Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

MyDailyChoice & HempWorx

Create your financial freedom with the hottest nutritional sprays on the planet!

Germer International

Germer International is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

USMD Holdings

USMD is a publicly held (NASDAQ: USMD), physician-led integrated healthcare system committed to exemplary patient care. Headquartered in Irving, Texas, USMD serves the Dallas-Fort Worth metropolitan area with more than 250 physicians and associate practitioners, and provides healthcare services to patients in just under 20 different specialties at its hospitals, nine cancer treatment centers and nearly 70 physician clinics. For more information about USMD, visit www.usmd.com.

Iterative Health

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.